Liabilities / Assets
35th percentile
Higher debt load relative to assets than 35% of similar nonprofits.
Translational Testing and Training
990 • Fiscal year 2017 • EIN 80-0079841
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.10x
Liabilities / Revenue
42nd percentile
Higher debt load relative to revenue than 42% of similar nonprofits.
Net Margin
10th percentile
Higher net margin than 10% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Revenue Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Balance Sheet
Assets
Down$10,306,660
Down $13,188,147 (-56%) from 2011
Net Assets
Down$9,308,420
Down $10,877,676 (-54%) from 2011
Liabilities
Down$998,240
Down $2,310,471 (-70%) from 2011
Revenue And Expenses
Revenue
Down$5,912,458
Down $2,119,881 (-26%) from 2011
Expenses
Down$7,224,684
Down $6,740,934 (-48%) from 2011
Net Income
Up-$1,312,226
Up $4,621,053 (+78%) from 2011
Historical Trend
Filing Detail Status
This 2017 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jul 1, 2016 to Jun 30, 2017
Mission and Program Overview
Mission
To provide high-value preclinical testing and training services to medical device, biologics, and pharmaceutical developers and manufacturers.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2017 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $10,306,660
- Liabilities
- $998,240
- Net assets
- $9,308,420
- Revenue
- $5,912,458
- Expenses
- $7,224,684
- Net income
- -$1,312,226